X-Linked Recessive Form of Nephrogenic Diabetes Insipidus in A 7-Year-Old Boy

1. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol. 2001; 63: 607-630.10.1146/annurev.physiol.63.1.607Search in Google Scholar

2. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab. 2000; 11(10): 406-410.10.1016/S1043-2760(00)00304-0Search in Google Scholar

3. Schöneberg T, Kostenis E, Liu J, Gudermann T, Wess J. Molecular aspects of vasopressin receptor function. Adv Exp Med Biol. 1998; 449: 347-358.10.1007/978-1-4615-4871-3_4410026824Search in Google Scholar

4. Robert J, Clauser ER. Vasopressin receptors: Structure/function relationships and signal transduction in target cells. J Soc Biol. 2005; 199(4): 351-359.10.1051/jbio:2005037Search in Google Scholar

5. Cannon JF. Diabetes insipidus: Clinical and experimental studies with consideration of genetic relationships. Arch Intern Med. 1995; 96: 215-272.10.1001/archinte.1955.0025013008901214397883Search in Google Scholar

6. Nakano KK. Familial nephrogenic diabetes insipidus. Hawaii Med J. 1969; 28: 205-208.Search in Google Scholar

7. van Lieburg AF, Knoers NVAM, Monnens LAH. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1999; 10(9): 1958-1964.10.1681/ASN.V109195810477148Search in Google Scholar

8. Hong CR, Kang HG, Choi HJ, Cho MH, Lee JW, Kang JH, et al. X-linked recessive nephrogenic diabetes insipidus: a clinicogenetic study. J Pediatr Endocrinol Metab. 2014; 27(1-2): 93-99.10.1515/jpem-2013-023124030030Search in Google Scholar

9. Seibold A, Brabet P, Rosenthal W, Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet. 1992; 51(5): 1078-1083.Search in Google Scholar

10. Bichet DG, Turner M, Morin D. Vasopressin receptor mutations causing nephrogenic diabetes insipidus. Proc Assoc Am Physicians. 1998; 110(5): 387-394.Search in Google Scholar

11. Bichet DG. Nephrogenic diabetes insipidus. Adv Chronic Kidney Dis. 2006; 13(2): 96-104.10.1053/j.ackd.2006.01.00616580609Search in Google Scholar

12. van den Ouweland AMW, Dreesen JCFM, Verdijk M, Knoers NVAM, Monnens LAH, et al. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet. 1992; 2(2): 99-102.10.1038/ng1092-991303271Search in Google Scholar

13. Wildin RS, Antush MJ, Bennett RL, Schoof JM, Scott CR. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet. 1994; 55(2): 266-277.Search in Google Scholar

14. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet. 1994; 55(2): 278-286.Search in Google Scholar

15. Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T, Inada M. Binding, intracellular transport, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest.1995; 96(4): 2043-2050.10.1172/JCI1182521858437560098Search in Google Scholar

16. Cheong HI, Park HW, Ha IS, Moon HN, Choi Y, Ko KW, et al. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron. 1997; 75(4): 431-437.10.1159/000189581Search in Google Scholar

17. Carroll P, Al-Mojalli H, Al-Abbad A, Al-Hassoun I, Al-Hamed M, Al-Amr R, et al. Novel mutations underlying nephrogenic diabetes insipidus in Arab families. Genet Med. 2006; 8(1): 443-447.10.1097/01.gim.0000223554.46981.7aSearch in Google Scholar

18. Bichet DG. Molecular and cellular biology of vasopressin and oxytocin receptors and action in the kidney. Curr Opin Nephrol Hypertens. 1994; 3(1): 46-53.10.1097/00041552-199401000-00006Search in Google Scholar

19. Bichet DG. Pathological aspects of water transport in the collecting ducts. Nephrologie. 1996; 17(7): 417-422.Search in Google Scholar

20. Alon U, Chan JCM. Hydrochlorothiazideamiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol. 1985; 5(1) 9-13.10.1159/000166896Search in Google Scholar

21. Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr. 1986; 108(2): 305-311.10.1016/S0022-3476(86)81010-1Search in Google Scholar

22. Morin D, Delenne AL, Kervran A. Congenital nephrogenic diabetes insipidus. Arch Pediatr. 2005; 12(1): 59-66.10.1016/j.arcped.2004.10.01115653057Search in Google Scholar

23. Cheong HI, Cho HY, Park HW, Ha IS, Choi Y. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones. Nephrology. 2007; 12(2): 113-117.10.1111/j.1440-1797.2006.00759.x17371330Search in Google Scholar

24. Los EL, Deen PM, Robben JH. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus. J Neuroendocrinol. 2010; 22(5): 393-399.10.1111/j.1365-2826.2010.01983.x20163515Search in Google Scholar

25. Bockenhauer D, Carpentier E, Rochdi D, van’t Hoff W, Breton B, Bernier V, et al. Vasopressin type 2 receptor V88M mutation: Molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol. 2010; 114(1): 1-10.10.1159/00024505919816050Search in Google Scholar

26. Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, Miller WL, et al. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf). 2009; 71(3): 388-393.10.1111/j.1365-2265.2008.03513.x588156919170711Search in Google Scholar

27. Robben JH, Deen PM. Pharmacological chaperones in nephrogenic diabetes insipidus: Possibilities for clinical application. BioDrugs. 2007; 21(3): 157-166.10.2165/00063030-200721030-0000317516711Search in Google Scholar

28. Robben JH, Sze M, Knoers NV, Deen PM. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: Relevance to therapy of nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2007; 292(1): 253-260.10.1152/ajprenal.00247.200616926443Search in Google Scholar

29. Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, et al. Pharmacological chaper-ones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest. 2000; 105(7): 887-895. 10.1172/JCI868837748210749568Search in Google Scholar